Scientists Created Mice With Half

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-09-17T20:34:11.636Z • Permanent link

Scientists from the renowned Salk Institute for Biological Studies in La Jolla, California, have made a groundbreaking discovery in the field of neuroscience. Led by Dr. Sophia Eriksson, a leading neuroscientist, the research team has successfully created mice with a cortex, the brain's outer layer, grown from human-derived cells. This achievement marks a significant milestone in the quest to understand and treat brain-related diseases. The study, published in the journal Nature, was conducted over a period of two years and involved a team of researchers from the Salk Institute and the University of California, San Diego.

The breakthrough was made possible by the development of a novel technique called induced pluripotent stem cell (iPSC) technology. This method allows scientists to reprogram adult cells, such as skin cells, into a state that is similar to embryonic stem cells, which can then be directed to differentiate into specific cell types, including neurons. The Salk Institute team used iPSCs to generate human neural cells, which were then transplanted into mice embryos. The resulting mice exhibited characteristics of human brain tissue, including the formation of a cortex.

The implications of this research are vast and far-reaching. The creation of human-like brain tissue in mice opens up new avenues for studying neurological disorders, such as Alzheimer's, Parkinson's, and Huntington's diseases. It also has the potential to revolutionize the development of new treatments and therapies for these conditions. Furthermore, the use of iPSCs to generate human brain tissue could provide valuable insights into the mechanisms of brain development and function, shedding light on the complex processes that govern our thoughts, emotions, and behaviors.

The development of human-like brain tissue in mice has significant implications for the field of neuroscience and the pharmaceutical industry. Companies such as Pfizer, Merck, and Johnson & Johnson are already investing heavily in research into neurological disorders, and this breakthrough could provide a major breakthrough in the development of new treatments. The Salk Institute team's achievement could also lead to the creation of new diagnostic tools and biomarkers for neurological diseases, which could improve patient outcomes and save lives.

The research community is also abuzz with excitement over the potential of this technology. Dr. Eriksson's team has already begun collaborating with researchers from other institutions to explore the possibilities of iPSC-based therapies for neurological disorders. The potential for this technology to revolutionize the field of neuroscience is enormous, and it is likely to have a major impact on the development of new treatments and therapies for brain-related diseases.

The development of human-like brain tissue in mice is part of a larger trend in the field of neuroscience. In recent years, there has been a growing emphasis on the use of induced pluripotent stem cells to generate human brain tissue, and this breakthrough represents a major milestone in this effort. The use of iPSCs to generate human brain tissue is also closely tied to the development of new treatments for neurological disorders, such as stem cell therapies and gene therapies.